Back to User profile » Dr Jiamin Cheng

Papers published by Dr Jiamin Cheng:


Original Research

Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study

Chen B, Zhang L, Cheng J, Wu T, Lei J, Yang X, Zhang R, Safadi R, Li Y, Si T, Lu Y

Drug Design, Development and Therapy 2022, 16:4429-4437

Published Date: 28 December 2022

Original Research

Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study

Chen B, Lei J, Zhao H, Dong J, Zeng Z, Li Y, Yu L, Zhou L, Jia A, Lu Y, Cheng J

Journal of Hepatocellular Carcinoma 2022, 9:1171-1185

Published Date: 8 November 2022

Case Series

Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases

Wu T, Zhang L, Zeng Z, Yan T, Cheng J, Miao X, Lu Y

OncoTargets and Therapy 2021, 14:5447-5453

Published Date: 18 December 2021

Original Research

Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels

Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z

Journal of Hepatocellular Carcinoma 2021, 8:1281-1295

Published Date: 27 October 2021